Clinical Trial Detail

NCT ID NCT02343939
Title Entospletinib Monotherapy and in Combination With Chemotherapy in Adults With Acute Myeloid Leukemia (AML)
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Gilead Sciences
Indications

acute myeloid leukemia

Therapies

Decitabine

Cytarabine + Daunorubicin

Entospletinib

Age Groups: adult

No variant requirements are available.